SCHEMBL10101787

SCHEMBL10101787

Cc1ccc(CO/N=C2\CCCc3cc(C)c(O)cc32)cc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAOA P21397 2/20 0.42
MAOB P27338 2/20 0.42
MAPT P10636 7/20 0.39
L3MBTL1 Q9Y468 5/20 0.39
MEN1 O00255 4/20 0.39
KMT2A Q03164 4/20 0.39
PLA2G1B P04054 1/20 0.39
ATG4B Q9Y4P1 1/20 0.39
ALDH1A1 P00352 7/20 0.38
LMNA P02545 2/20 0.38
RAB9A P51151 2/20 0.36
NPC1 O15118 2/20 0.34
CYP2C19 P33261 2/20 0.33
GAA P10253 2/20 0.33
ALOX12 P18054 3/20 0.33
MAPK1 P28482 3/20 0.33
HPGD P15428 2/20 0.33
KDM4E B2RXH2 1/20 0.33
CYP1A2 P05177 1/20 0.33
CYP3A4 P08684 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10101788 0.93 MAOA (0.36) MAOAMAOBMAPTL3MBTL1MEN1
SCHEMBL10101784 0.90 MAOA (0.45) MAOAMAOBMAPTL3MBTL1MEN1
SCHEMBL10102248 0.86 MAPT (0.40) MAOAMAOBMAPTMEN1KMT2A
SCHEMBL10101792 0.83 MAPT (0.34) MAPTL3MBTL1ALDH1A1LMNARAB9A
SCHEMBL10102274 0.82 L3MBTL1 (0.40) MAPTL3MBTL1MEN1KMT2AALDH1A1
SCHEMBL10101786 0.82 MAOB (0.39) MAOAMAOBMAPTL3MBTL1MEN1
SCHEMBL10102259 0.78 MAPT (0.41) MAOAMAOBMAPTMEN1KMT2A
SCHEMBL10101834 0.78 MAOA (0.33) MAOAMAOBMAPTALDH1A1CYP2C19
SCHEMBL13606752 0.76 ALDH1A1 (0.44) MAOAMAOBMAPTL3MBTL1MEN1
SCHEMBL10101795 0.76 TUBB4A (0.30)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8536157-B2 Non-steroidal compounds THE UNIVERSITY OF MELBOURNE (AU) 2013-09-17 US disclosed
US-20120046255-A1 NON-STEROIDAL COMPOUNDS THE UNIVERSITY OF MELBOURNE of ROYAL PARADE PARKVILLE (AU) 2012-02-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120046255-A1 NON-STEROIDAL COMPOUNDS PTGES2, PTGES, PTGES3 MAOA 2304/4885MAOB 2633/4885MAPT 2433/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.